# Most wouldn't pay more than $2,500 for a personalized cancer test

Canonical page: https://data.verasight.io/money/most-wouldnt-pay-more-than-2-500-for-a-personalized-cancer-test/

> Indexed question in Money & Finance.

## Reading

Most U.S. adults (69%) would not pay more than $2,500 for a highly reliable cancer test that comes with personalized treatment options, in a Verasight survey conducted Aug. 13-18, 2025.

About one-in-six (17%) would go as high as $5,000 and 6% as high as $10,000. A smaller tail would pay far more: 3% up to $20,000 and 5% more than $20,000 if necessary.

## Topline

What is the highest price you are willing to pay for a 95% reliable cancer biomarker test which gives you personalized treatment options?

Most wouldn't pay more than $2,500 for a personalized cancer test.

- Less than $2,500: 69.4%
- $2,500 - $5,000: 16.7%
- $5,001 - $10,000: 6.0%
- More than $20,000 if necessary: 5.3%
- $10,001 - $20,000: 2.5%

## Methodology

- Mode: Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting
- Population: United States adults
- Field dates: 2025-08-13 → 2025-08-18
- Base (unweighted): 1,000
- Margin of error: +/- 3.1%
- Module: Verasight JSM Omnibus Survey
- Sponsor: Verasight
- Weight variable: weight
- Weighting targets: age, race/ethnicity, sex, income, education, region, metropolitan status

## Source

- Canonical question URL: [https://reports.verasight.io/r/jsm-2025#willingness-to-pay-for-cancer-biomarker-test](https://reports.verasight.io/r/jsm-2025#willingness-to-pay-for-cancer-biomarker-test)

## Citation

Verasight JSM Omnibus Survey, fielded August 13-18, 2025, N=1,000 United States adults, +/- 3.1%.

Canonical question URL: [https://reports.verasight.io/r/jsm-2025#willingness-to-pay-for-cancer-biomarker-test](https://reports.verasight.io/r/jsm-2025#willingness-to-pay-for-cancer-biomarker-test)